Subgroup analyses of clinical effectiveness to support health technology assessments

Bayesian models for subgroup analysis in clinical trials

(2011) Hayley E Jones et al.   Clinical Trials

Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed

(2010) J. Hasford et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

No inconsistent trial assessments by NICE and IQWiG: different assessment goals may lead to different assessment results regarding subgroup analyses

(2010) Ralf Bender et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Confounding Control in Healthcare Database Research

(2010) M. Alan Brookhart et al.   MEDICAL CARE

Statistical resource needs to be increased in the European regulatory agencies

(2010) Oliver N. Keene et al.   PHARMACEUTICAL STATISTICS

Statisticians in the Pharmaceutical Industry: The 21st Century

(2009) Christy Chuang-Stein et al.   Statistics in Biopharmaceutical Research

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

(2008) Stephen D. Wiviott et al.   CIRCULATION

Subgroups and Heterogeneity in Cost-Effectiveness Analysis

(2008) Mark Sculpher   PHARMACOECONOMICS